Literature DB >> 9197523

MAD-related genes on 18q21.1, Smad2 and Smad4, are altered infrequently in esophageal squamous cell carcinoma.

C Maesawa1, G Tamura, S Nishizuka, T Iwaya, S Ogasawara, K Ishida, K Sakata, N Sato, K Ikeda, Y Kimura, K Saito, R Satodate.   

Abstract

The MAD (mothers against decapentaplegic)-related genes, Smad2 (former name MADR2 or JV18-1) and Smad4 (former name DPC4), have been identified on chromosome 18q21.1. We analyzed 30 primary esophageal squamous cell carcinomas (ESCC) and 7 cell lines derived from ESCC for intragenic mutations and loss of heterozygosity (LOH) of the Smad2 and Smad4 genes. LOH was detected in 5 of 14 (35%) informative cases. However, no mutations in either gene were detected in either the primary carcinomas or the cell lines, and only a G-to-A base transition within the 3'-untranslated region of the Smad4 gene was observed in a carcinoma. There were no homozygous deletions in either of the genes in the cell lines. MAD-related genes on chromosome 18q21.1 are altered infrequently in ESCC.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9197523      PMCID: PMC5921430          DOI: 10.1111/j.1349-7006.1997.tb00386.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  23 in total

1.  Allelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma.

Authors:  M T Barrett; M Schutte; S E Kern; B J Reid
Journal:  Cancer Res       Date:  1996-10-01       Impact factor: 12.701

2.  Xenopus Mad proteins transduce distinct subsets of signals for the TGF beta superfamily.

Authors:  J M Graff; A Bansal; D A Melton
Journal:  Cell       Date:  1996-05-17       Impact factor: 41.582

3.  Nomenclature: vertebrate mediators of TGFbeta family signals.

Authors:  R Derynck; W M Gelbart; R M Harland; C H Heldin; S E Kern; J Massagué; D A Melton; M Mlodzik; R W Padgett; A B Roberts; J Smith; G H Thomsen; B Vogelstein; X F Wang
Journal:  Cell       Date:  1996-10-18       Impact factor: 41.582

4.  Loss of heterozygosity at the DCC gene locus is not crucial for the acquisition of metastatic potential in oesophageal squamous cell carcinoma.

Authors:  C Maesawa; G Tamura; S Ogasawara; Y Suzuki; K Sakata; J Sugimura; S Nishizuka; N Sato; K Ishida; K Saito; R Satodate
Journal:  Eur J Cancer       Date:  1996-05       Impact factor: 9.162

Review 5.  Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta).

Authors:  A B Roberts; M B Sporn
Journal:  Growth Factors       Date:  1993       Impact factor: 2.511

6.  Inactivation of the CDKN2 gene by homozygous deletion and de novo methylation is associated with advanced stage esophageal squamous cell carcinoma.

Authors:  C Maesawa; G Tamura; S Nishizuka; S Ogasawara; K Ishida; M Terashima; K Sakata; N Sato; K Saito; R Satodate
Journal:  Cancer Res       Date:  1996-09-01       Impact factor: 12.701

7.  Somatic in vivo alterations of the JV18-1 gene at 18q21 in human lung cancers.

Authors:  K Uchida; M Nagatake; H Osada; Y Yatabe; M Kondo; T Mitsudomi; A Masuda; T Takahashi; T Takahashi
Journal:  Cancer Res       Date:  1996-12-15       Impact factor: 12.701

8.  Genetic characterization and cloning of mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster.

Authors:  J J Sekelsky; S J Newfeld; L A Raftery; E H Chartoff; W M Gelbart
Journal:  Genetics       Date:  1995-03       Impact factor: 4.562

9.  Two distinct regions of deletion on the long arm of chromosome 5 in differentiated adenocarcinomas of the stomach.

Authors:  G Tamura; S Ogasawara; S Nishizuka; K Sakata; C Maesawa; Y Suzuki; M Terashima; K Saito; R Satodate
Journal:  Cancer Res       Date:  1996-02-01       Impact factor: 12.701

Review 10.  Development of resistance mechanisms to the growth-inhibitory effects of transforming growth factor-beta during tumor progression.

Authors:  J Filmus; R S Kerbel
Journal:  Curr Opin Oncol       Date:  1993-01       Impact factor: 3.645

View more
  10 in total

1.  Loss of Dpc4 expression in colonic adenocarcinomas correlates with the presence of metastatic disease.

Authors:  A Maitra; K Molberg; J Albores-Saavedra; G Lindberg
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

2.  SMAD family member 3 (SMAD3) and SMAD4 repress HIF2α-dependent iron-regulatory genes.

Authors:  Xiaoya Ma; Nupur K Das; Cristina Castillo; Ayla Gourani; Ansu O Perekatt; Michael P Verzi; Yatrik M Shah
Journal:  J Biol Chem       Date:  2019-01-18       Impact factor: 5.157

3.  Topographical distributions of allelic loss in individual non-small-cell lung cancers.

Authors:  Y Yatabe; H Konishi; T Mitsudomi; S Nakamura; T Takahashi
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

Review 4.  Two sides of the story? Smad4 loss in pancreatic cancer versus head-and-neck cancer.

Authors:  Stephen P Malkoski; Xiao-Jing Wang
Journal:  FEBS Lett       Date:  2012-02-03       Impact factor: 4.124

5.  Loss of DPC4 expression and its correlation with clinicopathological parameters in pancreatic carcinoma.

Authors:  Zhan Hua; Yuan-Chun Zhang; Xiao-Ming Hu; Zhen-Geng Jia
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

6.  Genome-wide screening for genetic alterations in esophageal cancer by aCGH identifies 11q13 amplification oncogenes associated with nodal metastasis.

Authors:  Jianming Ying; Ling Shan; Jisheng Li; Lan Zhong; Liyan Xue; Hong Zhao; Lili Li; Cordelia Langford; Lei Guo; Tian Qiu; Ning Lu; Qian Tao
Journal:  PLoS One       Date:  2012-06-25       Impact factor: 3.240

Review 7.  Transforming growth factor-beta and breast cancer: Transforming growth factor-beta/SMAD signaling defects and cancer.

Authors:  M Kretzschmar
Journal:  Breast Cancer Res       Date:  2000-02-21       Impact factor: 6.466

8.  Nonrandom chromosomal imbalances in esophageal squamous cell carcinoma cell lines: possible involvement of the ATF3 and CENPF genes in the 1q32 amplicon.

Authors:  A Pimkhaokham; Y Shimada; Y Fukuda; N Kurihara; I Imoto; Z Q Yang; M Imamura; Y Nakamura; T Amagasa; J Inazawa
Journal:  Jpn J Cancer Res       Date:  2000-11

Review 9.  Transcription Factors in Cancer Development and Therapy.

Authors:  Kanchan Vishnoi; Navin Viswakarma; Ajay Rana; Basabi Rana
Journal:  Cancers (Basel)       Date:  2020-08-15       Impact factor: 6.575

10.  The Role of TGFβ Signaling in Squamous Cell Cancer: Lessons from Mouse Models.

Authors:  Adam B Glick
Journal:  J Skin Cancer       Date:  2012-12-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.